CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

0
STU:1CG (Switzerland)   Ordinary Shares
€ 40.80 (0%) Jan 10
At Loss
P/B:
1.71
Market Cap:
€ 3.24B ($ 3.34B)
Enterprise V:
€ 1.57B ($ 1.62B)
Volume:
-
Avg Vol (2M):
-
Trade In:

CRISPR Therapeutics AG Valuation Measures